Herbal granule plus chemo shows promise in aggressive lung cancer trial
NCT ID NCT07390565
First seen Feb 05, 2026 · Last updated May 10, 2026 · Updated 14 times
Summary
This study tests whether adding Yishen Qutong granules (a traditional Chinese medicine) to standard chemotherapy and immunotherapy can help people with extensive-stage small cell lung cancer live longer and feel better. About 308 participants will receive either the granules or a placebo alongside their regular treatment. The goal is to see if the combination improves disease control and quality of life while reducing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE-STAGE SMALL CELL LUNG CANCER (SCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College
Beijing, Chaoyang, 100021, China
Conditions
Explore the condition pages connected to this study.